Prevalence and Associated Factors of Hyperuricemia Among Cancer Patients Under Chemotherapy at Bugando Medical Centre in Mwanza. (Record no. 20140)

MARC details
000 -LEADER
fixed length control field 02943nam a22001937a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210728b |||||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Antony, Selina
Dates associated with a name CUHAS/BP/3000180/T/15
9 (RLIN) 19796
245 ## - TITLE STATEMENT
Title Prevalence and Associated Factors of Hyperuricemia Among Cancer Patients Under Chemotherapy at Bugando Medical Centre in Mwanza.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mwanza, Tanzania:
Name of publisher, distributor, etc. Catholic University of Health and Allied Sciences [CUHAS - Bugando]
-- Phone: +255 28 298 3384 :
-- Fax: +255 28 298 3386 :
-- Email: vc@bugando.ac.tz :
-- Website: www.bugando.ac.tz
Date of publication, distribution, etc. ©2018
300 ## - PHYSICAL DESCRIPTION
Extent xi; 29 Pages
Extent Includes Refferences and Appendices
520 ## - SUMMARY, ETC.
Summary, etc. ABSTRACT:<br/><br/>Background: Cancer patients on chemotherapy mostly experience high serum levels (hyperuricemia) due to high destruction of cells, mostly dividing cells (DNA and RNA). Although chemotherapy is associated with hyperuricemia among cancer patients in relation to chemotherapy is still unclear at Bugando medical center (BMC). Mwanza. This study aims to determine the prevalence and associated factors of hyperuricemia among cancer patients under chemotherapy at BMC, Mwanza.<br/><br/>Methodology: Across sectional hospital based was conducted at BMC, Mwanza from May to July 2018 involved cancer patients on chemotherapy admitted or attended at BMC cancer unit with an estimated sample size of 217. Blood will be collected from consenting study participants and processed for detection of uric acid by using automated method (COBAS). Data was analyzed by using STATA version 13.0. Continuous data was presented as (+/-SD) or median while categorical data was presented as fractions or percentage. Chi-square was used to show the association between hyperuricemia and associated risk factors. P value of <0.05was considered as statistical significance.<br/><br/>Results: The majority of the participant; 110(51.6%) were females, the commonest cancer types, 70(32.9%) were the reproductive system. Of the 85(39.7%) cancer patients with hyperuricemia, the highest prevalence was seen in reproductive system cancer, 33/70(38.8%), followed by lymphatic system cancer, 20/16(23.5%) and exocrine system cancer, 15/35(17.7%). Hyperuricemia was common in males with significant association (p=0.001), also significantly associated with cancer types (p = 0.009, and chemotherapeutic agents given; Emeset (p =0.001), Casodex (p =0.005), Goserelin (p = <0.001), Paclitaxel (p =0.o43), Dexamethasone (p =0.009), Cyclophosphamide (p = 0.015) and Carboplatin (p = 0.044).<br/><br/>Conclusion: the prevalence of hyperuricemia among cancer patients under chemotherapy at BMC 1I 39.7%, more prevalently in males than female. Sex, cancer types and chemotherapy treatment have an association with hyperuricemia.<br/>
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Pharmacy
9 (RLIN) 26693
General subdivision Biochemistry
9 (RLIN) 15676
General subdivision Molecular Biology
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 19703
9 (RLIN) 19763
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type UNDERGRADUATE DISSERTATIONS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   07/28/2021   UD0097 07/28/2021 07/28/2021 UNDERGRADUATE DISSERTATIONS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024